Patients with Atopic Dermatitis and Insufficient Response to Conventional Systemic Therapy in Germany: A Health Claims Data Analysis [0.03%]
德国阿特海 dermatitis 且对常规系统性治疗反应不足的患者：健康保险数据的分析
Carolina Schwedhelm,Leonie Kunk,Dorota Pawlowska-Phelan et al.
Carolina Schwedhelm et al.
Introduction: Atopic dermatitis (AD) is a prevalent, chronic, inflammatory skin disorder causing significant quality-of-life impairment. Some patients need systemic therapy depending on disease course and effectiveness of...
Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review [0.03%]
头皮分隔性皮炎生物制剂和小分子靶向药物治疗的系统评价
Kevin Díez-Madueño,Belén Argüello-Marcos,Diego Buendía-Castaño et al.
Kevin Díez-Madueño et al.
Introduction: Dissecting cellulitis of the scalp (DCS) is a chronic, relapsing neutrophilic scarring alopecia within the follicular occlusion spectrum. It shares clinical and pathogenic features with hidradenitis suppurat...
Genetic Markers of Tumor Multiplicity in Non-melanoma Skin Cancer: Associations of 19 SNPs in an Italian Cohort [0.03%]
非黑素瘤皮肤癌肿瘤多发的基因标志物：意大利人群中19个SNP的相关性分析
Irene Campana,Ylenia Aura Minafò,Giovanni Luca Scaglione et al.
Irene Campana et al.
Introduction: Ultraviolet exposure is the main environmental risk factor for non-melanoma skin cancers (NMSCs), but genetic susceptibility also contributes to variability in disease burden among individuals. ...
Yalda Salari,Moe Latt,Eva Lau et al.
Yalda Salari et al.
Introduction: Acne vulgaris is a common inflammatory skin disorder that imposes substantial psychosocial and quality-of-life burden. While most guidelines focus on facial involvement, acne frequently affects the trunk, wh...
Clinical Severity and Outcome Measures in Seborrheic Dermatitis: A Systematic Review [0.03%]
脂溢性皮炎临床严重程度和结局指标的系统评价
Sophia A Mense,Theresa Hopkins,Carmen Li et al.
Sophia A Mense et al.
Introduction: Seborrheic dermatitis (SD) is a common chronic inflammatory dermatosis associated with substantial symptom burden and impaired quality of life. Despite increasing interest in development of advanced therapie...
Alexander Böhner,Wanja Steinhauser,Rosi Wang et al.
Alexander Böhner et al.
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a significant impact on a patient's daily life, negatively affecting numerous psychological and physical aspects. Thus, patients with...
Targeting TYK2 in Cutaneous Autoimmunity: Deucravacitinib-Induced Remission of Discoid Lupus and Psoriasis with Supportive Confocal Microscopy Findings [0.03%]
TYK2在皮肤自身免疫性疾病中的靶向作用：Deucravacitinib诱导的盘状红斑狼疮和银屑病缓解及共焦显微镜支持发现
Francesco D&#x;Oria,Francesco Piscazzi,Paola Facheris et al.
Francesco D&#x;Oria et al.
Introduction: Cutaneous lupus erythematosus (CLE), particularly discoid lupus erythematosus (DLE), is a chronic autoimmune condition driven in part by type I interferon signaling. No systemic therapies are specifically ap...
Perceptions and Experiences of Patients Across All Skin Tones Living with Psoriasis in Canada [0.03%]
加拿大各肤色牛皮癣患者的感知和体验
H Chih-Ho Hong,Tessa Carr,Frankie Tai et al.
H Chih-Ho Hong et al.
Introduction: Psoriasis is a chronic inflammatory skin disease that significantly impacts patients' quality of life. Patients with skin of colour (SoC) often face unique barriers related to gaining access to care, diagnos...
Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy [0.03%]
皮肤与妊娠：妊娠期间的皮肤病表现及用药管理叙述性回顾
Maya Davis,Shelby Smith,Belle Skaggs et al.
Maya Davis et al.
Pregnancy greatly impacts skin health. Patients experience both benign skin changes during these 40 weeks and exacerbations or improvements of prior dermatologic disease. Some women may also experience pregnancy-specific dermatoses that can...
Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative Review [0.03%]
一种 potent、下一代TYK2变构抑制剂envudeucitinib：叙述性综述
April W Armstrong,James G Krueger,Bruce E Strober et al.
April W Armstrong et al.
Psoriasis is an immune-mediated inflammatory disease (IMID) impacting more than 40 million people globally and characterized by skin plaques, elevated systemic levels of inflammatory cytokines, and psychosocial burden. Many patients remain ...